Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06894108 · ClinicalTrials.gov registry record · NA
The Effectiveness of a Proprietary of a Botanical Extract on Sleep Quality
A NA study, sponsored by Nutraceuticals Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 89
- Enrollment target
NCT06894108: Completed NA study, sponsored by Nutraceuticals Research Institute.
NCT06894108 is a NA study that has completed, run by Nutraceuticals Research Institute. The registered enrollment target is 89 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06894108, a NA study, has completed, sponsored by Nutraceuticals Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 89 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the efficacy and superiority of a botanical based sleep product on sleep quality as compared to melatonin, among healthy female participants.
Primary Outcome
The NRI Sleep Scale is a validated measure of sleep health. It has 6 domains, each measured on a Likert scale, with higher scores indicating greater sleep disturbances.
Interventions
- DIETARY_SUPPLEMENT Melatonin
- DIETARY_SUPPLEMENT Proprietary Blend of Botanical Extracts
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2024-10-01 |
| Est. Completion | 2025-04-30 |
| Phase | NA |
What the finished NCT06894108 record still lists
NCT06894108 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 89 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Melatonin is the first listed.
NCT06894108 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06894108 about?
NCT06894108 is a clinical study titled "The Effectiveness of a Proprietary of a Botanical Extract on Sleep Quality". The purpose of this study is to evaluate the efficacy and superiority of a botanical based sleep product on sleep quality as compared to melatonin, among healthy female participants.
What is the current status of trial NCT06894108?
This trial is currently completed. It is a NA study. The enrollment target is 89 participants. The study started on 2024-10-01. Estimated completion is 2025-04-30.
What interventions are being tested in trial NCT06894108?
The interventions under investigation include: Melatonin (DIETARY_SUPPLEMENT), Proprietary Blend of Botanical Extracts (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06894108?
This trial is sponsored by Nutraceuticals Research Institute, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06894108's enrollment target sits among peer trials
89 972nd of 2000 higher than 1,029 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03682289 · 89 participants · Phase 2
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
- NCT04787939 · 89 participants · NA
Early Feeding After Oral Cavity Reconstruction
- NCT05480449 · 89 participants · Phase 1
Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)
- NCT05604131 · 89 participants · Phase 2
Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI